Horse Hair 10,000DU/ml solution for skin prick test

Nazione: Regno Unito

Lingua: inglese

Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)

Principio attivo:

Horse hair allergen extract

Commercializzato da:

Allergy Therapeutics (UK) Ltd

Codice ATC:

V04CL

INN (Nome Internazionale):

Horse hair allergen extract

Forma farmaceutica:

Solution for skin-prick test

Via di somministrazione:

Intraepidermal

Classe:

No Controlled Drug Status

Tipo di ricetta:

Never Valid To Prescribe As A VMP

Dettagli prodotto:

BNF: 03040201

Scheda tecnica

OBJECT 1
HORSE HAIR 10,000 DU/ML SOLUTION FOR SKIN PRICK
TEST
Summary of Product Characteristics Updated 10-Mar-2017 | Allergy
Therapeutics
1. Name of the medicinal product
Horse Hair 10,000 DU/ml
Solution for skin prick test
2. Qualitative and quantitative composition
Horse Hair 10,000 DU/ml in 2 ml
For the full list of excipients see Section 6.1.
3. Pharmaceutical form
Solution for skin prick test
A clear solution.
4. Clinical particulars
4.1 Therapeutic indications
This medicinal product is indicated for the diagnosis of allergic (IgE
– mediated) diseases (type 1 in the
classification of Coombs and Gell).
4.2 Posology and method of administration
Taking a careful case history is a vital part of the investigation of
a patient with allergy symptoms since it
will usually identify those allergens most likely to be clinically
significant. Skin testing will help to
confirm the significance of the likely causative allergens and
establish their relative importance.
Posology
_Paediatric population_
Prick testing in children is possible after the first year of life
depending on the child constitution, but in
general should not be performed before the age of 4.
Method of administration
The tests are usually carried out on the volar surface of the forearm:
In conditions of extreme outdoor
temperatures allow acclimatisation to room temperature: If test area
has been cleaned with water, alcohol
etc, wait at least two minutes to allow skin circulation to return to
normal.
Clean the skin with soap and water if necessary – but do not
sterilise with organic solvents or strong
antiseptics.
A ballpoint pen may be used to mark the skin (with suitable symbols)
adjacent to planned test sites to
identify the allergen and control solutions used.
The colours of the individual skin testing solutions vary depending on
the characteristics of the raw
material involved, e.g. pollens tend to be yellowish whilst dusts and
moulds in particular, are shades of
brown.
Since each vial is used more than once, aseptic precautions must be
suffici